Dr. Michael Christopher Fangerow, DO

Dr. Fangerow practices at Scripps Clinic OB-GYN La Jolla Campus in La Jolla, California.

Dr. Fangerow's NPI, 1952697740, was assigned on June 21, 2011. Dr. Fangerow graduated from Des Moines University in 2011. Dr. Fangerow holds California license 16904.

Dr. Fangerow's primary practice is Scripps Clinic OB-GYN La Jolla Campus, at 9850 Genesee Ave, La Jolla, CA 92037 in San Diego County. The practice phone is (858) 453-0753.

Dr. Fangerow's primary practice is Scripps Clinic OB-GYN La Jolla Campus in La Jolla, California. The medical group on file is Perlman Clinic. Dmand AI also links Dr. Fangerow to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fangerow practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Fangerow's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Fangerow is board certified in 2018 - 2026 by the CA State License. Dr. Fangerow is licensed in California.

Dmand AI lists atrial fibrillation and flutter, chronic hypertension, conjunctivitis, contact dermatitis, enlarged prostate, fatty liver, high cholesterol and intermittent racing heartbeat (PSVT) among the conditions Dr. Fangerow treats.

CMS data shows 148 Medicare services from Dr. Fangerow across 3 procedure codes in 2024, for 66 Medicare patients. Medicare paid $11,725 for them. Every service was in an office.

CMS counts 66 Medicare patients who saw Dr. Fangerow in 2024. The largest group is 65 to 74, with 42 patients. 62% of them have high blood pressure, and 50% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.19, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Fangerow's median patient age at 45, with 52% women.

In 2024, Dr. Fangerow wrote 2,763 Medicare Part D claims for 322 patients. 85% of them were for generic drugs. CMS names the drug for 2,143 of them, across 79 drugs with 11 or more claims each, at $231,796 in total drug cost. In 2023, CMS named 704 claims across 30 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Fangerow for performance year 2024, reported as part of a group. Dr. Fangerow accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fangerow as offering telehealth.

CMS Open Payments shows 49 general payments to Dr. Fangerow from 18 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $172.

Dmand AI lists 1 award for Dr. Fangerow, most recently Preceptor of the Year in 2022.

Dr. Fangerow graduated from Des Moines University in 2011. Dr. Fangerow is a member of American Society of Clinical Pathology.

Dr. Fangerow is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Humana. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.